Scotland Leads UK with Newborn Screening for Spinal Muscular Atrophy

Scotland has begun a pioneering pilot program to screen newborns for spinal muscular atrophy (SMA), a rare genetic disorder causing muscle wasting. This early detection initiative aims to improve treatment outcomes by identifying affected babies soon after birth. If successful, the program could prompt the adoption of SMA screening across the entire UK, influencing national health policy.